Form 4: MicroVision Director Converts RSUs to Common Stock

MicroVision Director Jeffrey A. Herbst acquired 22,007 shares of common stock through the vesting of restricted stock units on December 1, 2025.

Summary

• Jeffrey A. Herbst, a Director of MicroVision, Inc. (MVIS), acquired 22,007 shares of common stock.
• The acquisition occurred on December 1, 2025, through the vesting of restricted stock units (RSUs).
• The transaction price for these shares was $0.00, as they were distributed without payment on a unit-for-share basis.
• Following this transaction, Mr. Herbst beneficially owns 208,720 shares of MicroVision common stock.
• A previous Form 4 filed on June 6, 2025, incorrectly reported the total RSUs granted on June 5, 2025, as 87,462 instead of the correct amount of 88,208 RSUs. The current vesting calculation is based on the corrected amount.
• The RSUs granted on June 6, 2025, are scheduled to vest in four equal quarterly installments, contingent on Mr. Herbst's continued service as a director.

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-scheduled insider transaction (vesting of RSUs) which is a neutral event. The increase in direct beneficial ownership by a director is slightly positive as it aligns interests with shareholders, but the correction of a previous reporting error introduces a minor negative aspect.

Positives

• Director Jeffrey A. Herbst increased his direct beneficial ownership of MicroVision common stock by 22,007 shares, aligning his interests further with shareholders.
• The vesting of restricted stock units is a standard component of executive and director compensation, indicating continued commitment.

Negatives

• The transaction did not involve a direct cash purchase of shares by the director.
• A previous Form 4 filing contained an error regarding the total RSUs granted, requiring a correction in this filing.

Risks

• The vesting of future restricted stock units is contingent upon the reporting person's continued service as a director through each vesting date.

Future Outlook

The remaining RSUs granted on June 6, 2025, are scheduled to vest in three additional equal quarterly installments, with full vesting occurring on the earlier of the first anniversary of the grant date or the day prior to the 2026 Annual Meeting of Stockholders, provided the reporting person continues to serve as a director.

Industry Context

This is a routine insider transaction filing (Form 4) reporting the vesting of restricted stock units for a director. Such filings are common across all publicly traded companies and reflect standard executive and director compensation practices, which often include equity-based incentives to align management interests with shareholder value.

Stakeholder Impact

• Shareholders: The increase in direct beneficial ownership by a director may be viewed positively as it aligns management's interests with shareholder value.
• Employees/Management: The vesting of RSUs is a standard component of director compensation, reflecting the company's compensation structure.

Next Steps

• Future quarterly vesting installments of the remaining RSUs granted on June 6, 2025, will occur until fully vested.
• The reporting person must continue to serve as a director through each vesting date for the RSUs to vest.

Key Dates

Keywords

MicroVision, MVIS, Jeffrey A. Herbst, Director, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Common Stock, Corporate Governance